Skip to main content
SpringerLink
Log in

Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

To investigate the patient characteristics, disease progression, and associated risk factors in patients with multiple sclerosis (MS) with a progressive onset, we conducted a longitudinal population-based study of 359 patients (252 with primary progressive MS (PPMS) and 107 with progressive relapsing MS (PRMS)) in Lorraine, France.As outcome measures, we assessed the time from MS onset to reaching disability status scale (DSS) scores of 4, 6 and 7 and the time from assignment of DSS score of 6 to assignment of DSS score of 7.We studied the influence on these outcomes of sex, age of onset and symptoms of onset. We also studied the influence of the time from MS onset to assignment of DSS 6 on the time from MS onset to assignment of DSS 7.

There were no significant differences in the demographic data (gender and age at onset of MS) and clinical data (median time to DSS scores of 4, 6 and 7) between the patients with PPMS and PRMS suggesting such a distinction may be unnecessary. The male/female ratio in all 359 patients with MS with a progressive onset was 1/1.36. The median age at onset was 42.7 years (25% Q1 = 34.7; 75% Q3 = 50.0), was lower for male (40.5 years) than for female patients (44.2 years; p = 0.002). The median time to DSS scores of 4, 6 and 7 were (in years) 3.0 (95% CI = 2.8 to 3.7), 9.9 (95% CI = 9.0 to 10.6), and 17.0 (95% CI = 14.9 to 19.0). A cane was required in 25% of patients 5 years after onset and in 75% 15 years after onset.We did not find any significant unfluence of sex, age at onset, or symptoms at onset on the time from MS onset to assignment of scores 6 or 7 or on the time from the assignment of a score of 6 to the assignment of a score of 7.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andersson PB, Waubant E, Gee L, Goodkin DE (1999) Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. Arch Neurol 56:1138-142

    Article  CAS  PubMed  Google Scholar 

  2. Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ (1992) EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 55:671-76

    Article  CAS  PubMed  Google Scholar 

  3. Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. N Engl J Med 343:1430-438

    Article  CAS  PubMed  Google Scholar 

  4. Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126:770-82

    Article  PubMed  Google Scholar 

  5. Confavreux C, Vukusic S (2006) Natural history of multiple sclerosis: a unifying concept. Brain 129:606-16

    Article  PubMed  Google Scholar 

  6. Cottrell DA, Kremenchutzky M, Rice GP, Koopman W, Hader W, Baskerville J et al. (1999) The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122(Pt 4):625-39

    Article  PubMed  Google Scholar 

  7. De Seze J, Debouverie M, Waucquier N, Steinmetz G, Pittion S, Zephir H et al. (2007) Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria. Mult Scler 13:622-25

    Article  CAS  PubMed  Google Scholar 

  8. Ebers GC (2004) Natural history of primary progressive multiple sclerosis. Mult Scler 10(Suppl 1):S8–S13

    Article  PubMed  Google Scholar 

  9. Ebers GC (2005) Prognostic factors for multiple sclerosis: the importance of natural history studies. J Neurol 252 (Suppl 3):iii15–iii20

    Article  PubMed  Google Scholar 

  10. Ingle GT, Stevenson VL, Miller DH, Thompson AJ (2003) Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain 126:2528-536

    Article  CAS  PubMed  Google Scholar 

  11. Kremenchutzky M, Cottrell D, Rice G, Hader W, Baskerville J, Koopman W et al. (1999) The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain 122 (Pt 10):1941-950

    Article  PubMed  Google Scholar 

  12. Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC (2006) The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain 129:584-94

    Article  CAS  PubMed  Google Scholar 

  13. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-452

    CAS  PubMed  Google Scholar 

  14. Leary SM, Thompson AJ (2005) Primary Progressive Multiple Sclerosis Current and future treatment options. CNS Drugs 19:369-76

    Article  CAS  PubMed  Google Scholar 

  15. Lublin FD, Reingold SC for the National Multiple Sclerosis Society (USA) (1996) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907-11

    CAS  PubMed  Google Scholar 

  16. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-27

    Article  CAS  PubMed  Google Scholar 

  17. McDonnell GV, Hawkins SA (1998) Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J Neurol Neurosurg Psychiatry 64:451-54

    Article  CAS  PubMed  Google Scholar 

  18. McDonnell GV, Hawkins SA (2002) Primary progressive multiple sclerosis: increasing clarity but many unanswered questions. J Neurol Sci 199:1-5

    Article  CAS  PubMed  Google Scholar 

  19. Minderhoud JM, van der Hoeven JH, Prange AJ (1988) Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand 78:10-5

    Article  CAS  PubMed  Google Scholar 

  20. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58:840-46

    Article  PubMed  Google Scholar 

  21. Poser CM, Paty DW, Scheinberg L, MCDonald WI, Davis FA, Ebers GC et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-31

    Article  CAS  PubMed  Google Scholar 

  22. Runmarker B, Andersen O (1993) Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 116(Pt 1): 117-34

    Article  PubMed  Google Scholar 

  23. Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH et al. (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831-35

    Article  CAS  PubMed  Google Scholar 

  24. Thompson A (2004) Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis. Mult Scler 10(Suppl 1):S2–S7

    Article  PubMed  Google Scholar 

  25. Tremlett H, Paty D, Devonshire V (2005) The natural history of primary progressive MS in British Columbia, Canada.Neurology 65:1919-923

    Google Scholar 

  26. Vukusic S, Confavreux C (2003) Primary and secondary progressive multiple sclerosis. J Neurol Sci 206:153-55

    Article  PubMed  Google Scholar 

  27. Wolinsky JS (2004) The PROMiSe trial: baseline data review and progress report. Mult Scler 10(Suppl 1):S65–S71

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Neurology, Central Hospital, 54000, Nancy, France

    M. Debouverie MD, PhD, S. Louis, S. Pittion-Vouyovitch & H. Vespignani

  2. Centre of Clinical Epidemiology -INSERM-DHOS CIE 6, Dept. of Clinical Epidemiology and Evaluation, Marin Hospital, 54000, Nancy, France

    T. Roederer

  3. EA 4003, Nancy-Université, School of Public Health, Faculté de Médecine Avenue de la Forêt de Haye, 54500, Vandoeuvre-lès-Nancy, France

    M. Debouverie MD, PhD

Authors
  1. M. Debouverie MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Louis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Pittion-Vouyovitch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Roederer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Vespignani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Debouverie MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Debouverie, M., Louis, S., Pittion-Vouyovitch, S. et al. Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France. J Neurol 254, 1370–1375 (2007). https://doi.org/10.1007/s00415-007-0554-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-007-0554-3

Key words

Search

Navigation